Are there any clinical trials targeting RhoA in cancer?
Several clinical trials are underway to evaluate the efficacy of RhoA-targeted therapies in cancer. These trials aim to assess the safety and effectiveness of RhoA inhibitors, either alone or in combination with other therapies. While some early-phase trials have shown promising results, further research is needed to establish the clinical utility of targeting RhoA in cancer treatment.
